Physicians need to inform parents about the limited effectiveness of growth hormone therapy in satisfying the treatment goals of children with idiopathic short stature.
The history of the AMA's policy on anencephalic newborns as organ donors is a living example of what medical science can do sometimes conflicts with society's support or nonsupport of those possibilities.
Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication.
Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Sheldon Zink, PhD, Rachel Zeehandelaar, and Stacey Wertlieb, MBe
The benefits of the international presumed-consent policy are presented as a solution to the United States' current shortage of organs available for transplantation.